2m 2m 2m 2m 2m 2m 2m
MAZE THERA (MAZE)
NASDAQ
$24.65+$0.05 (+0.20%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.4BMarket Cap
- 5.60%1-Year Change
- BiotechnologyIndustry
MAZE THERA (MAZE)
$24.65+$0.05 (+0.20%)
MAZE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.60 | ||
Change | -$0.22 (-0.89%) | ||
Open | $25.14 | ||
High | $25.99 | ||
Low | $24.36 | ||
Previous Close | $24.82 | ||
Volume | 1,052,240 | ||
30-Day Average Volume | 440,417 | ||
1-Week Change | -6.14% | ||
1-Month Change | -9.92% | ||
1-Year Change | 5.60% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 55.5M | ||
Total Assets | $531.6M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$44.7M | ||
Free Cash Flow | -$15.2M | ||
EBIT | -$43.8M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $397.5M | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -32 | ||
PEG | 0 | ||
Price/Free Cash Flow | -90 | ||
Price/Operating Cash Flow | -91 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue